Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II StudyReiki Nishimura, Kazuo Tamura, Yuzo Hamada et al.|Chemotherapy|2005Cited by 13
Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial.Reiki Nishimura, Kazuo Tamura, Yoshiaki Rai et al.|PubMed|2012Cited by 3